Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Selective antagonism of endothelin-A-receptors improves outcome in both head trauma and focal stroke in rat.

Barone FC, Ohlstein EH, Hunter AJ, Campbell CA, Hadingham SH, Parsons AA, Yang Y, Shohami E.

J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S357-61.

PMID:
11078420
2.

SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.

Legos JJ, Lenhard SC, Haimbach RE, Schaeffer TR, Bentley RG, McVey MJ, Chandra S, Irving EA, Andrew A Parsons, Barone FC.

Exp Neurol. 2008 Jul;212(1):53-62. doi: 10.1016/j.expneurol.2008.03.011. Epub 2008 Mar 25.

PMID:
18462720
3.

A selective endothelin ET(A) receptor antagonist, SB 234551, improves cerebral perfusion following permanent focal cerebral ischemia in rats.

Zhang Y, Belayev L, Zhao W, Irving EA, Busto R, Ginsberg MD.

Brain Res. 2005 May 31;1045(1-2):150-6. Epub 2005 Apr 15.

PMID:
15910773
4.

The endothelin receptor antagonist SB 217242 reduces cerebral focal ischemic brain injury.

Barone FC, White RF, Elliott JD, Feuerstein GZ, Ohlstein EH.

J Cardiovasc Pharmacol. 1995;26 Suppl 3:S404-7.

PMID:
8587428
5.

Characterisation of SB-221420-A - a neuronal Ca(2+) and Na(+) channel antagonist in experimental models of stroke.

Campbell CA, Barone FC, Benham CD, Hadingham SJ, Harries MH, Harling JD, Hills JM, Lewis VA, Mackay KB, Orlek BS, White RF, Parsons AA, Hunter AJ.

Eur J Pharmacol. 2000 Aug 11;401(3):419-28.

PMID:
10936502
6.

Effects of LF 16-0687 Ms, a bradykinin B(2) receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia.

Zausinger S, Lumenta DB, Pruneau D, Schmid-Elsaesser R, Plesnila N, Baethmann A.

Brain Res. 2002 Sep 20;950(1-2):268-78.

PMID:
12231253
7.
8.

Neuroprotective profile of enoxaparin, a low molecular weight heparin, in in vivo models of cerebral ischemia or traumatic brain injury in rats: a review.

Stutzmann JM, Mary V, Wahl F, Grosjean-Piot O, Uzan A, Pratt J.

CNS Drug Rev. 2002 Spring;8(1):1-30. Review.

9.

Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat.

Candelario-Jalil E, González-Falcón A, García-Cabrera M, León OS, Fiebich BL.

Brain Res. 2004 May 8;1007(1-2):98-108.

PMID:
15064140
10.

Cardiovascular effects of endothelin-1 and endothelin antagonists in conscious, hypertensive ((mRen-2)27) rats.

Gardiner SM, March JE, Kemp PA, Bennett T.

Br J Pharmacol. 2000 Dec;131(8):1732-8.

11.

Chronic peripheral ouabain treatment affects the brain endothelin system of rats.

Di Filippo C, Filippelli A, Rinaldi B, Piegari E, Esposito F, Rossi F, D'Amico M.

J Hypertens. 2003 Apr;21(4):747-53.

PMID:
12658021
12.
13.
15.

Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a high-affinity and selective nonpeptide ETA receptor antagonist.

Ohlstein EH, Nambi P, Hay DW, Gellai M, Brooks DP, Luengo J, Xiang JN, Elliott JD.

J Pharmacol Exp Ther. 1998 Aug;286(2):650-6.

16.
17.

A rat model of endothelin-3-induced middle cerebral artery occlusion with controlled reperfusion.

Henshall DC, Butcher SP, Sharkey J.

Brain Res. 1999 Oct 2;843(1-2):105-11.

PMID:
10528116
18.

Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia.

Barone FC, Irving EA, Ray AM, Lee JC, Kassis S, Kumar S, Badger AM, Legos JJ, Erhardt JA, Ohlstein EH, Hunter AJ, Harrison DC, Philpott K, Smith BR, Adams JL, Parsons AA.

Med Res Rev. 2001 Mar;21(2):129-45. Review.

PMID:
11223862
20.

Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.

Allahtavakoli M, Moloudi R, Arababadi MK, Shamsizadeh A, Javanmardi K.

Brain Res. 2009 May 19;1271:121-7. doi: 10.1016/j.brainres.2009.03.040. Epub 2009 Mar 28.

PMID:
19332033

Supplemental Content

Support Center